NEW YORK, Feb. 24 (GenomeWeb News) - MDL Information Systems and Inpharmatica today said that MDL would serve as a non-exclusive distributor for Inpharmatica's Biopendium proteome annotation database.
Under the agreement, MDL, a wholly owned subsidiary of scientific publisher Elsevier with sales offices in 11 countries, will offer both installed and hosted versions of Biopendium worldwide, excluding Japan. Other terms of the agreement were not disclosed.
Inpharmatica said that the distribution agreement would allow it to devote more resources to building its drug discovery business.
Current subscribers to Biopendium include Pfizer, Aventis, Daiichi, Genentech, Serono, Riken, and UCB Pharma.